First human test: how kidneys process experimental drug
NCT ID NCT06962774
Summary
This early-stage study tested how kidney function affects how the body processes ESK-001, an experimental oral drug. Researchers gave a single dose to 16 participants with varying levels of kidney function and healthy volunteers. The main goal was to measure drug levels in the blood and check for safety signals to guide future dosing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advanced Pharma CR
Miami, Florida, 33147, United States
-
Floridian Clinical Research
Miami Lakes, Florida, 33016, United States
-
Orlando Clinical Research Center
Orlando, Florida, 32809, United States
-
Panax Clinical Research
Miami Lakes, Florida, 33014, United States
Conditions
Explore the condition pages connected to this study.